Molecule Name |
DB09211
|
DrugBank Groups |
Approved
|
Cluster No |
453
|
Smiles |
O=C1(C(C(C=CC(O)CC(CCCC)C)C(C1)O)CCCCC=CC(=O)O)
|
Download |
mol2, pdbqt
|
TPSA |
94,83
|
Non-H Atoms |
27
|
Non-C/H Atoms |
5
|
Metal-Atoms |
0
|
Electronegative Atoms |
5
|
Stereo Centers |
5
|
Rotatable Bonds |
13
|
Rings Closures |
1
|
Small Rings |
1
|
Aromatic Rings |
0
|
Aromatic Atoms |
0
|
sp3-Atoms |
19
|
Symmetric atoms |
0
|
cLogS |
-4,013
|
MW |
380,523
|
cLogP |
4,4655
|
HBA |
5
|
HBD |
3
|
Ro5 violations |
0
|
Druglikeness |
-10,963
|
DrugScore |
0,318389487392341
|
Mutagenic |
none
|
Tumorigenic |
none
|
Reproductive Effective |
none
|
Irritant |
none
|
Blood-Brain Barrier |
BBB+
|
Human Intestinal Absorption |
HIA+
|
Caco-2 Permeability |
Caco2+
|
P-glycoprotein Substrate |
Substrate
|
P-glycoprotein Inhibitor |
Non-inhibitor
|
P-glycoprotein Inhibitor 2 |
Non-inhibitor
|
Renal Organic Cation Transporter |
Non-inhibitor
|
Aqueous solubility |
-2,4571
|
Caco-2 Permeability 2 |
0,6218
|
Subcellular localization |
Mitochondria
|
CYP450 2C9 Substrate |
Non-substrate
|
CYP450 2D6 Substrate |
Non-substrate
|
CYP450 3A4 Substrate |
Substrate
|
CYP450 1A2 Inhibitor |
Non-inhibitor
|
CYP450 2C9 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Inhibitor |
Non-inhibitor
|
CYP450 2C19 Inhibitor |
Non-inhibitor
|
CYP450 3A4 Inhibitor |
Non-inhibitor
|
CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition 2 |
Non-inhibitor
|
AMES Toxicity |
Non AMES toxic
|
Carcinogens |
Non-carcinogens
|
Fish Toxicity |
High FHMT
|
Fish Toxicity (pLC50, mg/L) |
1,1395
|
Tetrahymena Pyriformis Toxicity |
High TPT
|
Tetrahymena Pyriformis Toxicity (pIGC50, ug/L) |
1,0247
|
Honey Bee Toxicity |
High HBT
|
Biodegradation |
Not ready biodegradable
|
Acute Oral Toxicity |
I
|
Rat Acute Toxicity (LD50, mol/kg) |
3,5626
|
Carcinogenicity (Three-class) |
Non-required
|